SciELO - Scientific Electronic Library Online

 
vol.18 special issue 35[T1 ENG]Pneumocystis jirovecii and SARS-CoV-2; COVID-19Let's guarantee the quality of respiratory samples to diagnose COVID-19 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nova

Print version ISSN 1794-2470

Abstract

NIETO-DUARTE, Gina et al. COVID-19: A Review of the Available Evidence Regarding Pediatric Population. Nova [online]. 2020, vol.18, n.spe35, pp.87-94.  Epub Jan 17, 2021. ISSN 1794-2470.  https://doi.org/10.22490/24629448.4191.

In the context of the COVID-19 pandemic, the adequate selection and appropriate use of previously acquired knowledge from similar historical situations and the one acquired lately amid the pandemic is vital to guarantee correct decision-making regarding the prevention, management and treatment of this disease in the pediatric population. Since the beginning of 2020, attention has shifted to controlling the pandemic and managing patients with this disease, the majority being those in the adult population. However, more severe courses of the disease have recently been observed in pediatric patients, and what was initially considered to be a harmless pathology in this population has generated greater alerts due to the presence of severe complications. Therefore, this review seeks to determine the latest prevention, diagnosis and treatment strategies endorsed and supported by scientific evidence, in order to provide the necessary tools to guarantee proper management and to reduce, as far as possible, the fatal outcomes in the pediatric population.

Keywords : Severe acute respiratory syndrome coronavirus 2; Pediatrics; Disease Management; Secondary Prevention.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )